Skip to main content
. 2023 Dec 10;10(1):e23400. doi: 10.1016/j.heliyon.2023.e23400

Table 4.

Physicochemical properties of the identified compounds from EAF for good oral bioavailability.

Compound
Lipinski Rules
Lipinski's
Violations

MW
HBA
HBD
Log P
MR
≤500 ≤10 ≤5 ≤5 40–130 ≤1
Cyclopropane, nonyl- 168.32 0 0 4.73 57.68 0
Phenol,2,4-bis(1,1-dimethylethyl)- 206.32 1 1 3.09 67.01 0
Dodecanoic acid, methyl ester 214.34 2 0 4.10 65.89 0
E−14-Hexadecenal 238.41 1 0 5.13 78.75 1
Tridecanoic acid, 12-methyl-, methyl ester 242.40 2 0 4.75 75.50 0
E−15-Heptadecenal 252.44 1 0 5.50 83.56 1
9-Hexadecenoic acid, methyl ester, (Z)- 268.43 2 0 5.26 84.64 1
Hexadecanoic acid, methyl ester 270.45 2 9 5.54 85.12 2
1-Heneicosanol 312.57 1 1 7.25 104.22 1
n-Heptadecanol-1 256.5 1 1 7.8 82.34 1
9,12-Octadecadienoic acid, methyl ester 294.47 2 0 5.69 93.98 1
9-Octadecenoic acid (Z)-, methyl ester 296.49 2 0 5.95 94.26 1
11-Octadecenoic acid, methyl ester 296.49 2 9 5.95 94.26 2
Methyl stearate 298.50 2 0 6.24 94.73 1
Nonacos-1-ene 406.77 0 0 11.21 141.04 2

MW, molecular weight (g/mol); HBA, hydrogen bond acceptor; HBD, hydrogen bond donor; Log P, lipophilicity; MR, molar refractivity.